Menu Search
Equities

Krsnaa Diagnostics Ltd

KRSNAA:NSI

Krsnaa Diagnostics Ltd

Actions
Health CareMedical Equipment and Services
  • Price (INR)911.55
  • Today's Change11.55 / 1.28%
  • Shares traded69.40k
  • 1 Year change+43.55%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 10:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Nov-23
  • 15-Aug-24
  • 19-Sep-24
  • 17-Oct-24
  • 07-Nov-24
Select bar for recommendation details.
Recommendations07-Nov-24
Buy3
Outperform0
Hold0
Sell0
Strong Sell0

Share price forecast in INR

The 3 analysts offering 12 month price targets for Krsnaa Diagnostics Ltd have a median target of 975.00, with a high estimate of 1,026.00 and a low estimate of 955.00. The median estimate represents a 6.56% increase from the last price of 915.00.
High12.1%1,026.00
Med6.6%975.00
Low4.4%955.00

Dividends

In 2024, Krsnaa Diagnostics Ltd reported a dividend of 2.50 INR, which represents a 9.09% decrease from last year. The 2 analysts covering the company expect dividends of 11.15 INR for the upcoming fiscal year, an increase of 346.00%.
Div growth (TTM)-9.09%
More ▼

Earnings history & estimates in INR

On Oct 25, 2024, Krsnaa Diagnostics Ltd reported 2nd quarter 2025 earnings of 5.92 per share.
The next earnings announcement is expected on Feb 14, 2025.
Average growth rate+17.68%
Krsnaa Diagnostics Ltd reported annual 2024 earnings of 17.31 per share on May 18, 2024.
Average growth rate-12.98%
More ▼

Revenue history & estimates in INR

Krsnaa Diagnostics Ltd had 2nd quarter 2025 revenues of 1.86bn. This missed the 1.94bn consensus estimate of the 2 analysts following the company. This was 33.50% above the prior year's 2nd quarter results.
Average growth rate+4.68%
Krsnaa Diagnostics Ltd had revenues for the full year 2024 of 6.20bn. This was 27.20% above the prior year's results.
Average growth rate+17.08%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.